Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 13451-13500 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03909737
Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
PHASE4Active, not recruiting
99,700 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04052555
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
PHASE1Active, not recruiting
42 participants
Started: Sep 24, 2020 · Completed: Apr 24, 2026
5 conditions1 sponsor14 locations
NCT04574609
Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.
NAActive, not recruiting
27 participants
Started: Sep 24, 2020 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT04480567
AAV Gene Therapy Study for Subjects with PKU
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06431126
Nature and Animal-assisted Activities
NAActive, not recruiting
13 participants
Started: Sep 24, 2020 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT04422132
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks
PHASE2Active, not recruiting
134 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT04604301
Celtra Quatro Crown Study
NAActive, not recruiting
48 participants
Started: Sep 24, 2020 · Completed: Nov 1, 2027
3 conditions2 sponsors1 location
NCT04526665
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
PHASE3Active, not recruiting
161 participants
Started: Sep 24, 2020 · Completed: Dec 1, 2028
1 condition1 sponsor115 locations
NCT05736523
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
N/AActive, not recruiting
28 participants
Started: Sep 23, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors2 locations
NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
NAActive, not recruiting
600 participants
Started: Sep 23, 2020 · Completed: Mar 31, 2025
9 conditions3 sponsors1 location
NCT04560127
Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer
PHASE2Active, not recruiting
20 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05249153
Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery
NAActive, not recruiting
84 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04569773
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
N/AActive, not recruiting
43 participants
Started: Sep 23, 2020 · Completed: Sep 23, 2026
1 condition1 sponsor8 locations
NCT04497844
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
PHASE3Active, not recruiting
696 participants
Started: Sep 23, 2020 · Completed: Nov 1, 2027
1 condition1 sponsor387 locations
NCT04501276
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
PHASE1Active, not recruiting
72 participants
Started: Sep 23, 2020 · Completed: Feb 1, 2025
1 condition1 sponsor4 locations
NCT03978624
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
PHASE2Active, not recruiting
20 participants
Started: Sep 23, 2020 · Completed: Nov 22, 2026
1 condition3 sponsors2 locations
NCT04448886
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
PHASE2Active, not recruiting
110 participants
Started: Sep 23, 2020 · Completed: Jun 1, 2027
4 conditions3 sponsors8 locations
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
PHASE2Active, not recruiting
362 participants
Started: Sep 23, 2020 · Completed: Nov 23, 2027
4 conditions1 sponsor38 locations
NCT03666559
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
PHASE2Active, not recruiting
8 participants
Started: Sep 22, 2020 · Completed: Mar 23, 2024
1 condition1 sponsor1 location
NCT04503148
Anesthesia and Cancer Study: Renal Cell Carcinoma
NAActive, not recruiting
562 participants
Started: Sep 22, 2020 · Completed: Dec 22, 2025
1 condition1 sponsor1 location
NCT04390672
Multivessel TALENT
NAActive, not recruiting
1,550 participants
Started: Sep 22, 2020 · Completed: Sep 30, 2026
7 conditions1 sponsor1 location
NCT05871489
Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
N/AActive, not recruiting
800 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
2 conditions4 sponsors3 locations
NCT04563676
Physiopathology and Sequelae of COVID-19 Infection
NAActive, not recruiting
400 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04624698
iStent Inject New Enrollment Post-Approval Study
NAActive, not recruiting
358 participants
Started: Sep 22, 2020 · Completed: May 31, 2026
2 conditions1 sponsor3 locations
NCT05530642
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
NAActive, not recruiting
192 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2024
8 conditions13 sponsors1 location
NCT04565067
Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans
N/AActive, not recruiting
83 participants
Started: Sep 22, 2020 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04621916
Preventing Inhibitor Recurrence Indefinitely
PHASE4Active, not recruiting
52 participants
Started: Sep 21, 2020 · Completed: Apr 20, 2025
2 conditions2 sponsors1 location
NCT04623944
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
PHASE1Active, not recruiting
61 participants
Started: Sep 21, 2020 · Completed: Jul 31, 2039
4 conditions1 sponsor8 locations
NCT04469491
Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
PHASE2Active, not recruiting
74 participants
Started: Sep 20, 2020 · Completed: Sep 30, 2025
3 conditions12 sponsors7 locations
NCT04632901
A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
N/AActive, not recruiting
300 participants
Started: Sep 20, 2020 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT04400331
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
PHASE3Active, not recruiting
154 participants
Started: Sep 18, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors34 locations
NCT04280718
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
PHASE2Active, not recruiting
229 participants
Started: Sep 18, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor147 locations
NCT04563650
COVID-19 Serology and Immunosenescence
NAActive, not recruiting
98 participants
Started: Sep 18, 2020 · Completed: Nov 30, 2024
4 conditions1 sponsor1 location
NCT04447651
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
N/AActive, not recruiting
6 participants
Started: Sep 17, 2020 · Completed: Aug 31, 2026
5 conditions4 sponsors1 location
NCT05155722
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy with BAT1308 in Advanced Solid Tumors
PHASE1Active, not recruiting
148 participants
Started: Sep 17, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04533581
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)
PHASE2Active, not recruiting
61 participants
Started: Sep 17, 2020 · Completed: May 31, 2028
1 condition1 sponsor30 locations
NCT04545177
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NAActive, not recruiting
18 participants
Started: Sep 17, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04358900
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
N/AActive, not recruiting
132 participants
Started: Sep 17, 2020 · Completed: Nov 30, 2025
6 conditions2 sponsors1 location
NCT04557098
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
194 participants
Started: Sep 17, 2020 · Completed: May 28, 2027
1 condition1 sponsor51 locations
NCT04578418
Effect of Collagen Supplementation on Tendinopathy
NAActive, not recruiting
64 participants
Started: Sep 16, 2020 · Completed: May 1, 2025
1 condition3 sponsors1 location
NCT04544046
Supportive Oncology Care At Home RCT
NAActive, not recruiting
300 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT04568044
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
N/AActive, not recruiting
128 participants
Started: Sep 16, 2020 · Completed: Jan 1, 2025
3 conditions1 sponsor2 locations
NCT04064827
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
PHASE3Active, not recruiting
16 participants
Started: Sep 16, 2020 · Completed: Mar 31, 2027
2 conditions1 sponsor15 locations
NCT04522336
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
PHASE1Active, not recruiting
16 participants
Started: Sep 16, 2020 · Completed: Jul 18, 2027
19 conditions2 sponsors1 location
NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
PHASE2Active, not recruiting
51 participants
Started: Sep 16, 2020 · Completed: Mar 16, 2026
4 conditions1 sponsor5 locations
NCT04551742
Social & Contextual Impact on Children Undergoing Liver Transplantation
N/AActive, not recruiting
500 participants
Started: Sep 16, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor8 locations
NCT06880289
Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer
PHASE2Active, not recruiting
91 participants
Started: Sep 16, 2020 · Completed: Jul 31, 2027
1 condition1 sponsor2 locations
NCT04551807
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
PHASE3Active, not recruiting
788 participants
Started: Sep 16, 2020 · Completed: Apr 1, 2026
2 conditions1 sponsor15 locations
NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy
PHASE2Active, not recruiting
154 participants
Started: Sep 16, 2020 · Completed: Mar 30, 2026
3 conditions1 sponsor46 locations
NCT05602935
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
PHASE2Active, not recruiting
29 participants
Started: Sep 16, 2020 · Completed: Dec 30, 2026
6 conditions1 sponsor1 location